Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland News Journal.

Tania Zarak Announces Season Finale of 'Cable a Tierra' and Upcoming Season Two
Acclaimed podcast to conclude its first season on December 16; new episodes return in February 2025. REYKJAVÍK, ICELAND, December 9, 2024 /EINPresswire.com/ -- International producer and cultural expert Tania Zarak is set to air the season...

NATO Allies must not reward the aggressor but must ensure a just and durable peace in Ukraine
25 May 2025 DAYTON, OHIO – Negotiations for a just and durable peace in Ukraine must be pursued with unity and resolve and must not reward the aggressor, undermine Ukraine’s sovereignty, or embolden authoritarian regimes, the NATO Parliamentary...

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...

Notice of Results and Investor Presentation
Reykjavík, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Notice of Results and Investor Presentation TORONTO, ONTARIO – 7 November 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine...

Holding(s) in Company
Reykjavík, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Plan3 Launches the Airline ImPax Report, New Monthly Research Helping Airlines Improve Passenger Disruption Management
Leveraging Disruption Data to Transform Airline Recovery Strategies and Enhance Customer Experience REYKJAVIK, ICELAND, December 5, 2024 /EINPresswire.com/ -- Each year, hundreds of millions of passengers are impacted by delays and...

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...

Holding(s) in Company
Reykjavík, Oct. 31, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
REYKJAVIK, Iceland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine...

Miscellaneous
Reykjavik, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Appointment of Nomad and Joint Broker TORONTO, ONTARIO – October 28, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land...

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...

Successful Completion of 2024 Exploration Field Season
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Successful Completion of 2024 Exploration Field Season **Completion of full 2024 >8,600m exploration programme ahead of schedule** ***First drilling...

Schedule 2(g) Disclosure
Reykjavik, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Schedule 2(g) Disclosure TORONTO, ONTARIO – 22 October 2024 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development...

Block Listing Six Monthly Return
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Block Listing Six Monthly Return TORONTO, ONTARIO – October 24, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ), an independent mine development company...

Global Lactose Free Food Market Forecast To Reach $29103.34 Billion By 2029 With 11.7% Annual Growth
The Business Research Company's Global Lactose Free Food Market Forecast To Reach $29103.34 Billion By 2029 With 11.7% Annual Growth LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The Business Research Company’s...

Holding(s) in Company
NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq Minerals Ltd. 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if...

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI) Inclusion criteria include minimum market capitalization and daily trading volumes REYKJAVIK, Iceland, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a...

Total Voting Rights and Exercise of Stock Options
Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Total Voting Rights and Exercise of Stock Options TORONTO, ONTARIO – 14 October 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an...

Holding(s) in Company
Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...